Maria Themeli

iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests

Themeli, M., Chhatta, A., Boersma, H., Prins, H. J., Cordes, M., de Wilt, E., Farahani, A. S., Vandekerckhove, B., van der Burg, M., Hoeben, R. C., Staal, F. J. T. & Mikkers, H. M. M., 11 Feb 2020, In : Stem Cell Reports. 14, 2, p. 300-311 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

Naik, J., Themeli, M., de Jong-Korlaar, R., Ruiter, R. W. J., Poddighe, P. J., Yuan, H., de Bruijn, J. D., Ossenkoppele, G. J., Zweegman, S., Smit, L., Mutis, T., Martens, A. C. M., van de Donk, N. W. C. J. & Groen, R. W. J., 28 Feb 2019, In : Haematologica. 104, 3, p. e100-e103

Research output: Contribution to journal › Letter › Academic › peer-review

Combined CD28 and 4-1BB costimulation potentiates affinity-tuned chimeric antigen receptor-engineered t cells

Drent, E., Poels, R., Ruiter, R., van de Donk, N. W. C. J., Zweegman, S., Yuan, H., de Bruijn, J., Sadelain, M., Lokhorst, H. M., Groen, R. W. J., Mutis, T. & Themeli, M., 1 Jan 2019, In : Clinical Cancer Research. 25, 13, p. 4014-4025 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Depreter, B., Weening, K. E., Vandepoele, K., Essand, M., De Moerloose, B., Themeli, M., Cloos, J., Hanekamp, D., Moors, I., D' Hont, I., Denys, B., Uyttebroeck, A., Van Damme, A., Dedeken, L., Snauwaert, S., Goetgeluk, G., De Munter, S., Kerre, T., Vandekerckhove, B., Lammens, T. & 1 others, Philippé, J., 1 Aug 2019, In : Haematologica.

Research output: Contribution to journal › Article › Academic › peer-review